Recruiting Ankylosing Spondylitis Studies in Chestnut Hill
About Ankylosing Spondylitis Clinical Trials in Chestnut Hill
Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.
There are currently 1 ankylosing spondylitis clinical trials recruiting participants in Chestnut Hill, MA. These studies are seeking a combined 180 participants. Research is being sponsored by AstraZeneca. Clinical trial participation is free and participants receive study-related medical care at no cost.
Ankylosing Spondylitis Clinical Trials in Chestnut Hill — FAQ
Are there ankylosing spondylitis clinical trials in Chestnut Hill?
Yes, there are 1 ankylosing spondylitis clinical trials currently recruiting in Chestnut Hill, MA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Chestnut Hill?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chestnut Hill research site will contact you about next steps.
Are clinical trials in Chestnut Hill free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chestnut Hill studies also compensate for your time and travel.
What ankylosing spondylitis treatments are being tested?
The 1 active trials in Chestnut Hill are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.
Data updated March 2, 2026 from ClinicalTrials.gov